Co-Diagnostics, Inc.
CODX
$0.34
-$0.01-2.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 507.90K | 569.40K | 567.60K | 770.00K | 675.90K |
| Total Other Revenue | 0.00 | 434.30K | 2.93M | 3.15M | 6.65M |
| Total Revenue | 507.90K | 1.00M | 3.50M | 3.92M | 7.32M |
| Cost of Revenue | 335.10K | 606.20K | 786.20K | 999.10K | 3.71M |
| Gross Profit | 172.90K | 397.50K | 2.71M | 2.92M | 3.61M |
| SG&A Expenses | 15.66M | 18.62M | 19.59M | 20.64M | 19.92M |
| Depreciation & Amortization | 1.20M | 1.28M | 1.33M | 1.38M | 1.33M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.04M | 39.76M | 41.87M | 44.00M | 47.32M |
| Operating Income | -35.53M | -38.75M | -38.37M | -40.08M | -40.00M |
| Income Before Tax | -33.33M | -35.95M | -35.81M | -37.58M | -37.38M |
| Income Tax Expenses | -1.15M | 38.30K | 46.60K | 57.40K | 3.90M |
| Earnings from Continuing Operations | -32.18 | -35.99 | -35.86 | -37.64 | -41.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.18M | -35.99M | -35.86M | -37.64M | -41.28M |
| EBIT | -35.53M | -38.75M | -38.37M | -40.08M | -40.00M |
| EBITDA | -34.33M | -37.47M | -37.05M | -38.70M | -38.67M |
| EPS Basic | -0.98 | -1.14 | -1.16 | -1.24 | -1.38 |
| Normalized Basic EPS | -0.67 | -0.76 | -0.76 | -0.81 | -0.81 |
| EPS Diluted | -0.99 | -1.15 | -1.17 | -1.24 | -1.38 |
| Normalized Diluted EPS | -0.67 | -0.76 | -0.76 | -0.81 | -0.81 |
| Average Basic Shares Outstanding | 133.92M | 126.53M | 123.54M | 121.34M | 119.93M |
| Average Diluted Shares Outstanding | 133.92M | 126.53M | 123.54M | 121.34M | 119.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |